ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 140 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $50,000 | +8.7% | 10,600 | 0.0% | 0.00% | – |
Q3 2019 | $46,000 | -94.9% | 10,600 | -93.2% | 0.00% | -100.0% |
Q2 2019 | $906,000 | -54.0% | 155,400 | -69.6% | 0.00% | -83.3% |
Q1 2019 | $1,970,000 | +139.7% | 511,600 | +16.4% | 0.01% | +100.0% |
Q4 2018 | $822,000 | -23.6% | 439,600 | +159.2% | 0.01% | 0.0% |
Q1 2017 | $1,076,000 | +75.8% | 169,600 | +48.3% | 0.01% | +50.0% |
Q4 2016 | $612,000 | -5.0% | 114,400 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $644,000 | – | 114,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,642,959 | $25,186,000 | 3.76% |
MSD Partners, L.P. | 15,151,516 | $26,061,000 | 2.11% |
MSD Partners, L.P. | 7,575,758 | $13,030,000 | 1.05% |
MAGNOLIA CAPITAL ADVISORS LLC | 418,569 | $720,000 | 0.61% |
STEEL GROVE CAPITAL ADVISORS, LLC | 1,080,000 | $1,858,000 | 0.33% |
EAM Investors, LLC | 454,625 | $782,000 | 0.17% |
Allred Capital Management, LLC | 158,000 | $271,000 | 0.17% |
Boxer Capital, LLC | 1,500,000 | $2,580,000 | 0.14% |
GSA CAPITAL PARTNERS LLP | 608,037 | $1,046,000 | 0.14% |
CHIRON CAPITAL MANAGEMENT, LLC | 116,860 | $201,000 | 0.14% |